You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 October 2025 - Oncology company BeOne Medicines Ltd (NASDAQ:ONC) (HKEX:06160) (SSE:688235) announced on Monday that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for sonrotoclax, its investigational BCL2 in...
13 October 2025 - Biopharmaceutical company AstraZeneca PLC (LSE: AZN (STO: AZN) (Nasdaq: AZN) announced on Monday that it has reached a historic agreement with the administration of President Donald J. Trump to lower prescription medicine costs for ...
13 October 2025 - Hong Kong-based Ascletis Pharma Inc (HKEX: 1672) has selected ASC35, a once-monthly, potentially best-in-class subcutaneously (SQ) administered GLP-1 receptor (GLP-1R)/GIP receptor (GIPR) dual peptide agonist, as a clinical developm...
13 October 2025 - South Korean biopharmaceutical company GC Biopharma (KS:006280) announced on Monday that it has signed an agreement with Curevo Vaccine to secure contract manufacturing (CMO) rights for amezosvatein (development name: CRV-101), a re...
13 October 2025 - Danish pharmaceutical company H. Lundbeck A/S (CPH:HLUN-A) announced on Monday that its investigational drug bexicaserin, for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs), has been gr...
10 October 2025 - Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) announced on Friday that it has entered into a definitive agreement to acquire Orbital Therapeutics, a privately held biotechnology company developing RNA-based medicines tha...
10 October 2025 - South Korean biopharmaceutical company Celltrion Inc announced on Thursday that the US Food and Drug Administration (FDA) has approved EYDENZELT (aflibercept-boav), its biosimilar referencing EYLEA (aflibercept), for the treatment o...